Cytogenetic evolution correlates with poor prognosis in myelodysplastic syndrome
Authors:
- Xiao-Qin WangXWXiao-Qin Wang
- 1 January 2010
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 196 (2) , 159-166
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromesBritish Journal of Haematology, 2000
- World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997Journal of Clinical Oncology, 1999
- Cross‐validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogeneticsBritish Journal of Haematology, 1999
- MyelodysplasiaNew England Journal of Medicine, 1999
- Prediction of 18-month survival in patients with primary myelodysplastic syndrome a regression model and scoring system based on the combination of chromosome findings and the bournemouth scoreCancer Genetics and Cytogenetics, 1995
- Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patientsBlood, 1989
- Bone marrow karyotype and prognosis in primary myelodysplastic syndromesEuropean Journal of Haematology, 1988
- Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemiaBritish Journal of Haematology, 1988
- Myelodysplastic syndromes: a scoring system with prognostic significanceBritish Journal of Haematology, 1985
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982